Furman-Assaf S - Search Results

1

Non-invasive multiple cancer screening using trained detection canines and artificial intelligence: a prospective double-blind study.

Half E, Ovcharenko A, Shmuel R, Furman-Assaf S, Avdalimov M, Rabinowicz A, Arber N. Half E, et al. Among authors: furman assaf s. Sci Rep. 2024 Nov 15;14(1):28204. doi: 10.1038/s41598-024-79383-2. Sci Rep. 2024. PMID: 39548246 Free PMC article.

2

A Prospective, Randomized, Double-Blind, Split-Face, Comparative Study to Evaluate the Efficacy and Safety of DKL23 and Juvéderm Volift for Correcting Moderate-to-Severe Nasolabial Folds.

Alimohammadi M, Furman-Assaf S, Nilsson J. Alimohammadi M, et al. Among authors: furman assaf s. Aesthet Surg J. 2024 Oct 15;44(11):1218-1226. doi: 10.1093/asj/sjae133. Aesthet Surg J. 2024. PMID: 38874166 Free PMC article. Clinical Trial.

3

Bioavailability of calcium in an enriched postbiotic system compared to calcium citrate in healthy postmenopausal females; A randomized, double-blind, comparator-controlled, crossover study.

Friling M, Haber A, Furman-Assaf S, Israel D, Harari G, Evans M, Crowley DC, Ouwehand AC, Ivanir E. Friling M, et al. Among authors: furman assaf s. Front Nutr. 2023 Mar 15;10:1073622. doi: 10.3389/fnut.2023.1073622. eCollection 2023. Front Nutr. 2023. PMID: 37006928 Free PMC article.

4

Attitudes and perceived knowledge of health professionals on the food labelling reform in Israel.

Furman-Assaf S, Accos-Carmel M, Kolobov T, Blaychfeld-Magnazi M, Endevelt R, Tamir O. Furman-Assaf S, et al. Public Health Nutr. 2023 Jul;26(7):1513-1521. doi: 10.1017/S1368980023000447. Epub 2023 Mar 15. Public Health Nutr. 2023. PMID: 36919667 Free PMC article.

5

Taxation of sugar sweetened beverages and unhealthy foods: a qualitative study of key opinion leaders' views.

Tamir O, Cohen-Yogev T, Furman-Assaf S, Endevelt R. Tamir O, et al. Among authors: furman assaf s. Isr J Health Policy Res. 2018 Jul 31;7(1):43. doi: 10.1186/s13584-018-0240-1. Isr J Health Policy Res. 2018. PMID: 30064503 Free PMC article.

6

Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).

Gozes I, Iram T, Maryanovsky E, Arviv C, Rozenberg L, Schirer Y, Giladi E, Furman-Assaf S. Gozes I, et al. Among authors: furman assaf s. J Alzheimers Dis. 2014;40 Suppl 1:S23-36. doi: 10.3233/JAD-131664. J Alzheimers Dis. 2014. PMID: 24503616

7

NAP alpha-aminoisobutyric acid (IsoNAP).

Gozes I, Schirer Y, Idan-Feldman A, David M, Furman-Assaf S. Gozes I, et al. Among authors: furman assaf s. J Mol Neurosci. 2014 Jan;52(1):1-9. doi: 10.1007/s12031-013-0103-8. J Mol Neurosci. 2014. PMID: 24458740

8

[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].

Furman-Assaf S, Tamir O, Marom E, Arieli M, Shemer J. Furman-Assaf S, et al. Harefuah. 2010 Jul;149(7):470-5, 479. Harefuah. 2010. PMID: 21465764 Hebrew.

9

[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].

Tamir O, Friedman N, Furman-Assaf S, Marom E, Arieli M, Shemer J. Tamir O, et al. Among authors: furman assaf s. Harefuah. 2010 Jul;149(7):466-9, 479. Harefuah. 2010. PMID: 21465763 Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters